VacV Biotherapeutics
PrivateLast Round
Grant
Aug 28, 2024
Total Funding Raised
$3.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VacV Biotherapeutics operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Grant round in August 2024.
VacV Biotherapeutics is a biotechnology company developing a novel cancer immunotherapy platform based on its proprietary oncolytic virus technology to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VacV Biotherapeutics Comparables
Compare VacV Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omios Biologics | 86% | |
| ReIGNITE Therapeutics | 83% | |
| KaliVir Immunotherapeutics | 81% |
For institutional investors. Book with your work email.
VacV Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 28, 2024 | ||||
| Seed | Oct 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VacV Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 1407% MoM.
- Apr 19, 2026
Monthly visitors increased 91% MoM.
For institutional investors. Book with your work email.
VacV Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VacV Biotherapeutics's valuation, stock price, and market status.
Is VacV Biotherapeutics a public or private company?
VacV Biotherapeutics is a private company.
What is the current stock price of VacV Biotherapeutics?
VacV Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks VacV Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VacV Biotherapeutics worth (valuation)?
Valuation information for VacV Biotherapeutics is not publicly available.
Can I buy VacV Biotherapeutics stock?
VacV Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VacV Biotherapeutics's last funding round?
VacV Biotherapeutics's most recent funding round was Grant on August 28, 2024.
Who are the main investors in VacV Biotherapeutics?
Key investors in VacV Biotherapeutics include Innovate UK.
Will VacV Biotherapeutics IPO soon?
No public IPO plans have been announced for VacV Biotherapeutics.
How can I track VacV Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in VacV Biotherapeutics's shares on secondary markets.